156 related articles for article (PubMed ID: 8218602)
1. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
[TBL] [Abstract][Full Text] [Related]
2. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
[TBL] [Abstract][Full Text] [Related]
3. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
[TBL] [Abstract][Full Text] [Related]
4. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
Lawrence KM; Falkowski J; Jacobson RR; Horton RW
Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
[TBL] [Abstract][Full Text] [Related]
5. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
6. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
[TBL] [Abstract][Full Text] [Related]
7. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
Cook EH; Arora RC; Anderson GM; Berry-Kravis EM; Yan SY; Yeoh HC; Sklena PJ; Charak DA; Leventhal BL
Life Sci; 1993; 52(25):2005-15. PubMed ID: 7684805
[TBL] [Abstract][Full Text] [Related]
8. Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay.
Jurado N; Torner C; Heinze G; López G; Mendoza-Sotelo J; Lazo-Langner A; Moreno J
Arch Med Res; 2003; 34(5):422-7. PubMed ID: 14602510
[TBL] [Abstract][Full Text] [Related]
9. Further studies on platelet serotonin transporter binding in depression.
Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
[TBL] [Abstract][Full Text] [Related]
10. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
Andersson A; Adolfsson R; Eriksson K; Marcusson J
Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
[TBL] [Abstract][Full Text] [Related]
11. Platelet [3H]paroxetine binding in panic disorder.
Maguire KP; Norman TR; Apostolopoulos M; Judd FK; Burrows GD
J Affect Disord; 1995 Feb; 33(2):117-22. PubMed ID: 7759659
[TBL] [Abstract][Full Text] [Related]
12. [3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers.
Stein MB; Delaney SM; Chartier MJ; Kroft CD; Hazen AL
Biol Psychiatry; 1995 Feb; 37(4):224-8. PubMed ID: 7711158
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.
Greenberg BD; Tolliver TJ; Huang SJ; Li Q; Bengel D; Murphy DL
Am J Med Genet; 1999 Feb; 88(1):83-7. PubMed ID: 10050973
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
Andersson A; Marcusson J
Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
[TBL] [Abstract][Full Text] [Related]
15. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
[TBL] [Abstract][Full Text] [Related]
16. Platelet serotonergic functions and light therapy in seasonal affective disorder.
Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
[TBL] [Abstract][Full Text] [Related]
17. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients.
Arora RC; Fichtner CG; O'Connor F; Crayton JW
Life Sci; 1993; 53(11):919-28. PubMed ID: 8366759
[TBL] [Abstract][Full Text] [Related]
19. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
[TBL] [Abstract][Full Text] [Related]
20. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
Segonzac A; Schoemaker H; Langer SZ
J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
